Sanofi (SNY) Total Liabilities (2009 - 2025)

Sanofi has disclosed Total Liabilities across 13 years of filings, most recently posting $14.0 billion for Q4 2025.

• Total Liabilities for Q4 2025 came in at $14.0 billion, down 76.35% year-over-year; the trailing twelve-month figure through Dec 2025 was $14.0 billion (down 76.35% YoY), and the FY2025 annual result was $14.0 billion, down 76.35% from the prior year.
• Total Liabilities came in at $14.0 billion for Q4 2025 at Sanofi, down from $59.1 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $59.1 billion in Q4 2024 to a low of $14.0 billion in Q4 2025.
• The 5-year median for Total Liabilities is $56.4 billion (2023), against an average of $48.3 billion.
• Across the five-year window, Total Liabilities jumped 180.43% in 2021 and sank 76.35% in 2025, its largest moves.
• Sanofi's Total Liabilities stood at $59.0 billion in 2021, then decreased by 10.16% to $53.0 billion in 2022, then increased by 6.45% to $56.4 billion in 2023, then rose by 4.75% to $59.1 billion in 2024, then tumbled by 76.35% to $14.0 billion in 2025.
• The last three Total Liabilities figures came in at $14.0 billion (Q4 2025), $59.1 billion (Q4 2024), and $56.4 billion (Q4 2023), per Business Quant data.